通过VavCre介导的Gbe删除,在高氏病中建模骨髓微环境和造血失调
Glenn Belinsky1, Jiapeng Ruan1, Nima Fattahi1
1Department of Medicine (Digestive Diseases), Yale School of Medicine, The Anylan Center, 300 Cedar St, New Haven, Connecticut 06519, United States.
Human molecular genetics
|April 8, 2025
概括
一种新的小鼠模型,具有造血特异性Gba淘汰,被开发用于研究高氏病 (GD). 该模型揭示了遗传背景影响GD严重程度和免疫系统变化,有助于生物标志物发现.
科学领域:
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
背景情况:
- 氏病 (Gaucher disease,简称GD) 是一种由Gba突变引起的溶酶体储存障碍,导致葡萄糖大脑酶缺乏和基质积累.
- GD会影响造血系,导致免疫失调,但现有的模型缺乏造血特异性.
- 研究造血特异性影响需要避免非造血细胞中基因缺失的模型.
研究的目的:
- 为研究高氏病创建一个特定于造血细胞的Gba淘汰赛小鼠模型.
- 调查遗传背景对GD病原和免疫变化的影响.
- 确定GD的潜在生物标志物和治疗点.
主要方法:
- 通过使用Vav-Cre和Gabfl/fl小鼠,生成了一个血液形成特异性的Gba淘汰赛小鼠模型.
- 将小鼠逆向交叉到129X1/SvJ和C57BL/6J背景,以评估遗传影响.
- 确认了Gba切除,测量了葡萄糖大脑酶活性,分析了基质积累,并进行了转录和免疫细胞解卷分析.
主要成果:
- 在Vav-CreGba淘汰赛模型中,在血液细胞中有效地进行了Gba删除,肝脏重组是最小的.
- VavCre 129 GD小鼠表现出降低的葡萄糖大脑化酶活性,增加的 GlcCer 和 GlcSph,高切尔细胞透,以及改变的免疫细胞群.
- 转录组分析揭示了上调的炎症和溶酶体通路,GPNMB被确定为潜在的生物标志物.
结论:
- 特定于造血细胞的Gba淘汰模型是研究GD病理生理学和免疫失调的宝贵工具.
- 在这个模型中,遗传背景显著影响了GD严重程度和免疫格局.
- 该模型促进了对GD生物标志物发现和针对造血和免疫机制的治疗策略的研究.
相关概念视频
Hematopoiesis
8.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.1K
Differentiation of Common Myeloid Progenitor Cells
3.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K
Regulation of Hematopoietic Stem Cells
3.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Bone Disorders
8.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
8.0K
Role of Hematopoietic Growth Factors
3.9K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.9K
Bone Marrow Sampling and Transplants
3.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K


